TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy. (2017)
Attributed to:
MSCTRAIL for lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/20013078.2017.1265291
PubMed Identifier: 28326166
Publication URI: http://europepmc.org/abstract/MED/28326166
Type: Journal Article/Review
Volume: 6
Parent Publication: Journal of extracellular vesicles
Issue: 1
ISSN: 2001-3078